Streptococcus pneumoniae and lytic antibiotic therapy: are we adding insult to injury during invasive pneumococcal disease and sepsis?
Streptococcus pneumoniae (S. pneumoniae), otherwise known as 'the pneumococcus', is a fascinating microbe that continues to pose a significant problem to public health. Currently there are no specific National Institute for Clinical Excellence (NICE) or British Thoracic Society (BTS) clini...
Saved in:
Published in | Journal of medical microbiology Vol. 66; no. 8; pp. 1253 - 1256 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
England
01.08.2017
|
Online Access | Get full text |
Cover
Loading…
Abstract | Streptococcus pneumoniae (S. pneumoniae), otherwise known as 'the pneumococcus', is a fascinating microbe that continues to pose a significant problem to public health. Currently there are no specific National Institute for Clinical Excellence (NICE) or British Thoracic Society (BTS) clinical guidelines referring to the treatment of invasive pneumococcal infection. NICE clinical guidelines suggest the use of lytic β-lactam antibiotic regimens for the management of community-acquired pneumonia and bacterial meningitis; infections for which S. pneumoniae is a likely causative organism. Lytic antibiotics have been shown to increase the release of pneumolysin (the highly inflammatory and damaging toxin of the pneumococcus), thus theoretically increasing host damage, which may lead to a decline of clinical outcomes in vulnerable patients. In light of this information, should the use of non-lytic antibiotics, such as quinolones, rifamycins and macrolides, be considered for the treatment of invasive pneumococcal disease? |
---|---|
AbstractList | Streptococcus pneumoniae (S. pneumoniae), otherwise known as 'the pneumococcus', is a fascinating microbe that continues to pose a significant problem to public health. Currently there are no specific National Institute for Clinical Excellence (NICE) or British Thoracic Society (BTS) clinical guidelines referring to the treatment of invasive pneumococcal infection. NICE clinical guidelines suggest the use of lytic β-lactam antibiotic regimens for the management of community-acquired pneumonia and bacterial meningitis; infections for which S. pneumoniae is a likely causative organism. Lytic antibiotics have been shown to increase the release of pneumolysin (the highly inflammatory and damaging toxin of the pneumococcus), thus theoretically increasing host damage, which may lead to a decline of clinical outcomes in vulnerable patients. In light of this information, should the use of non-lytic antibiotics, such as quinolones, rifamycins and macrolides, be considered for the treatment of invasive pneumococcal disease? |
Author | Mitchell, Tim J Brown, Lauren April Mitchell, Andrea M |
Author_xml | – sequence: 1 givenname: Lauren April surname: Brown fullname: Brown, Lauren April organization: 1iBMedSci, The University of Birmingham, Birmingham, UK – sequence: 2 givenname: Andrea M surname: Mitchell fullname: Mitchell, Andrea M organization: 2Pneumococcal Research Group, Institute of Microbiology and Infection, College of Medical and Dental Sciences, The University of Birmingham, Birmingham, UK – sequence: 3 givenname: Tim J surname: Mitchell fullname: Mitchell, Tim J organization: 2Pneumococcal Research Group, Institute of Microbiology and Infection, College of Medical and Dental Sciences, The University of Birmingham, Birmingham, UK |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28792379$$D View this record in MEDLINE/PubMed |
BookMark | eNo9kEtLxDAUhYMoOj52riVLF3bMczJxIzL4AsGFui5pckcztE1NUmX-gL_bDh1d3cPl4xz4DtFuG1pA6JSSKSVaX66aZkqmhBAp5A6aUKF4IWdC7KIJIYwVbEblATpMaUUIVZzrfXTA5kozrvQE_bzkCF0ONljbJ9y10Deh9QawaR2u19nbIWVf-bCJ-QOi6dZX2ETA3wPknG_fsW9TX2ecw5BWfVxj18fx_2WS_4Jt72bE1Nj5BCaNCwm65NP1MdpbmjrByfYeobe729fFQ_H0fP-4uHkqLNcyFzM7p8ToSjs-YwKIYYbSiitLBQfmCLdMzJUEwQ2Xdl5pqJRcGi6cZVYsgR-h87G3i-Gzh5TLxicLdW1aCH0qqWZK6sGMGtCLEbUxpBRhWXbRNyauS0rKjflyMF-ScjQ_4Gfb5r5qwP3Df6r5L7Rug_k |
CitedBy_id | crossref_primary_10_1021_acsinfecdis_9b00344 crossref_primary_10_3390_molecules24162902 crossref_primary_10_1128_Spectrum_00318_21 crossref_primary_10_3390_metabo11120821 crossref_primary_10_1007_s40259_023_00580_y crossref_primary_10_1186_s12879_020_4901_7 crossref_primary_10_12688_f1000research_14226_1 crossref_primary_10_1016_j_ccm_2018_08_008 crossref_primary_10_1021_acs_jmedchem_0c00520 crossref_primary_10_1097_MCP_0000000000000571 crossref_primary_10_1016_j_heliyon_2022_e12620 |
Cites_doi | 10.1371/journal.pone.0092355 10.1186/1472-6750-14-16 10.1111/jth.12047 10.4103/0970-2113.99248 10.1186/s12866-016-0881-6 10.1136/thx.2009.121434 10.1002/9783527659685 10.1159/000220828 10.1128/JB.00114-12 10.1183/09059180.00008911 10.4049/jimmunol.1401624 10.1136/adc.2010.191718 10.1111/j.1365-2958.1991.tb00812.x 10.3855/jidc.4711 10.1128/CMR.00018-12 10.2217/17460913.3.4.397 10.4161/viru.27135 10.1111/j.1471-4159.2004.02837.x 10.1086/511159 10.1084/jem.20.4.363 10.1074/jbc.M501236200 10.1007/s00249-015-1106-x 10.12688/f1000research.7657.1 10.1186/s13054-015-1021-7 10.1128/AAC.47.8.2649-2654.2003 |
ContentType | Journal Article |
DBID | NPM AAYXX CITATION 7X8 |
DOI | 10.1099/jmm.0.000545 |
DatabaseName | PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1473-5644 |
EndPage | 1256 |
ExternalDocumentID | 10_1099_jmm_0_000545 28792379 |
Genre | Journal Article |
GroupedDBID | --- -~X 18M 2WC 4.4 53G 5GY 5RE 5RS AAYEP ABOCM ACGFO ACPEE ADBBV ADCDP AENEX AFOSN ALMA_UNASSIGNED_HOLDINGS BAWUL C45 CS3 DIK DU5 E3Z EBS EJD F5P GX1 H13 L7B M5~ NPM OBC OBS OEB OFXIZ OK1 OVD OWW P0W P2P RGM TEORI TR2 VVN W8F WOQ YFH YQY AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c395t-6c810a9b9d3624e0a2a11b37c143e2d03c24875e43a35c8b9eb75fa34dc2c4fe3 |
ISSN | 0022-2615 |
IngestDate | Fri Oct 25 11:37:37 EDT 2024 Fri Dec 06 01:10:47 EST 2024 Tue Oct 15 23:57:10 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c395t-6c810a9b9d3624e0a2a11b37c143e2d03c24875e43a35c8b9eb75fa34dc2c4fe3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://doi.org/10.1099/jmm.0.000545 |
PMID | 28792379 |
PQID | 1927593797 |
PQPubID | 23479 |
PageCount | 4 |
ParticipantIDs | proquest_miscellaneous_1927593797 crossref_primary_10_1099_jmm_0_000545 pubmed_primary_28792379 |
PublicationCentury | 2000 |
PublicationDate | 2017-08-01 |
PublicationDateYYYYMMDD | 2017-08-01 |
PublicationDate_xml | – month: 08 year: 2017 text: 2017-08-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Journal of medical microbiology |
PublicationTitleAlternate | J Med Microbiol |
PublicationYear | 2017 |
References | (R5) 2016 Gualerzi (R24) 2013 R23 R22 R25 R27 R26 (R2) 2016 (R19) 2014 R28 (R7) 2013 (R21) 2015 R3 R4 R6 R8 R9 R30 R10 R32 R31 R12 R11 R33 R14 R13 R16 R15 Horaud (R1) 2013 R18 R17 Gupta (R20) 2012; 29 Lobanovska (R29) 2017; 90 |
References_xml | – ident: R16 doi: 10.1371/journal.pone.0092355 – ident: R9 doi: 10.1186/1472-6750-14-16 – ident: R17 doi: 10.1111/jth.12047 – volume: 29 start-page: S27 year: 2012 ident: R20 article-title: Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults publication-title: Lung Ind doi: 10.4103/0970-2113.99248 contributor: fullname: Gupta – year: 2015 ident: R21 article-title: Bacterial meningitis and meningococcal septicaemia – ident: R12 doi: 10.1186/s12866-016-0881-6 – ident: R18 doi: 10.1136/thx.2009.121434 – year: 2013 ident: R24 article-title: Antibiotics: targets, mechanisms and resistance doi: 10.1002/9783527659685 contributor: fullname: Gualerzi – start-page: 939 volume-title: Streptococci and the Host year: 2013 ident: R1 contributor: fullname: Horaud – ident: R31 doi: 10.1159/000220828 – ident: R10 doi: 10.1128/JB.00114-12 – ident: R3 doi: 10.1183/09059180.00008911 – ident: R15 doi: 10.4049/jimmunol.1401624 – ident: R23 doi: 10.1136/adc.2010.191718 – ident: R14 doi: 10.1111/j.1365-2958.1991.tb00812.x – ident: R33 doi: 10.3855/jidc.4711 – volume: 90 start-page: 135 year: 2017 ident: R29 article-title: Penicillin's discovery and antibiotic resistance lessons for the future? publication-title: Yale J Biol Med contributor: fullname: Lobanovska – ident: R6 doi: 10.1128/CMR.00018-12 – ident: R28 doi: 10.2217/17460913.3.4.397 – ident: R4 doi: 10.4161/viru.27135 – ident: R27 doi: 10.1111/j.1471-4159.2004.02837.x – ident: R22 doi: 10.1086/511159 – year: 2013 ident: R7 – year: 2016 ident: R5 article-title: Sepsis: recognition, diagnosis and early management. NICE Guideline – ident: R11 doi: 10.1084/jem.20.4.363 – ident: R30 doi: 10.1074/jbc.M501236200 – year: 2016 ident: R2 article-title: Pneumococcal disease – ident: R13 doi: 10.1007/s00249-015-1106-x – year: 2014 ident: R19 article-title: Pneumonia in adults: diagnosis and management – ident: R25 doi: 10.12688/f1000research.7657.1 – ident: R32 doi: 10.1186/s13054-015-1021-7 – ident: R26 doi: 10.1128/AAC.47.8.2649-2654.2003 – ident: R8 |
SSID | ssj0017339 |
Score | 2.3038206 |
Snippet | Streptococcus pneumoniae (S. pneumoniae), otherwise known as 'the pneumococcus', is a fascinating microbe that continues to pose a significant problem to... |
SourceID | proquest crossref pubmed |
SourceType | Aggregation Database Index Database |
StartPage | 1253 |
Title | Streptococcus pneumoniae and lytic antibiotic therapy: are we adding insult to injury during invasive pneumococcal disease and sepsis? |
URI | https://www.ncbi.nlm.nih.gov/pubmed/28792379 https://search.proquest.com/docview/1927593797 |
Volume | 66 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9RAFB7WiuKLaL2tN0bQJ0lNMjObji8iohZhfWphnwxzC0SaC01iqT_A3-2ZSzZpa0F9CSEzmwNzvj35zpzLIPSSxdoYIWQkeGEiKuIskiqVkS6UZgUjWSqto7j-ujo4ol82bLNYfJtlLQ293FM__1hX8j9ahWegV1sl-w-a3b4UHsA96BeuoGG4_pWObUi57RuwaWroXre1GUB0KXxE4PjM92K1RSGNvfWlVq7Dk033OoVpOpS0dMNxb1loWX-HNR5rF8v6h3DZ7f7NVswU0nEyOtN2ZXchOXDGcasQBqrKqd_TpQ0AW5ptauDDJ1O6x7rsXYrqNudSTNu28zGAWghshZ0L-BqOeXPw4fHWlmYkYivfAPKSLQfuam15Ve3Z7Duglmw-DRarrZxewecDluqPpLnQO3scuoau20aJ9myFz5ttClCSEcJDMQQIezMXZZtEhx-fZyxXuCGOjhzeQbfDGuP3HhR30cLUu-iGP1n0bBfdXIeciXvo1zmU4AklGDSIHUrwhBIcUPIWA0bwKUxyGMEeI7hvsMcI9hjBI0bwHCM4YMRJ8Bh5dx8dffp4-OEgCqdvRIpw1kcrtZ_EgkuugeNQE4tUJIkkmQKGbVIdE5VaZ9dQIghT-5IbmbFCEKpVqmhhyAO0Uze1eYSwhH99qlkcCwMOgpYCTECRGM4p5ZLEYolejSuct77JSu6TI3gOSsltB1urlCV6MS5_DlbQhrZEbZqhy8FPyRgwbZ4t0UOvl-2bRj0-vnLkCbo14fMp2ulPBvMMuGYvnzvA_AZkwIbo |
link.rule.ids | 314,780,784,27924,27925 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Streptococcus+pneumoniae+and+lytic+antibiotic+therapy%3A+are+we+adding+insult+to+injury+during+invasive+pneumococcal+disease+and+sepsis%3F&rft.jtitle=Journal+of+medical+microbiology&rft.au=Brown%2C+Lauren+April&rft.au=Mitchell%2C+Andrea+M&rft.au=Mitchell%2C+Tim+J&rft.date=2017-08-01&rft.eissn=1473-5644&rft_id=info:doi/10.1099%2Fjmm.0.000545&rft_id=info%3Apmid%2F28792379&rft.externalDocID=28792379 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-2615&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-2615&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-2615&client=summon |